The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Blood-Brain Delivery Methods Using Nanotechnology
Open accessAbstract
Pathologies of the brain, of which brain cancer, Alzheimer’s disease, Parkinson’s disease, stroke, and multiple sclerosis, are some of the most prevalent, and that presently are poorly treated due to the difficulties associated with drug development, administration, and targeting to the brain. The existence of the blood-brain barrier, a selective permeability system which acts as a local gateway against circulating foreign substances, represents the key challenge for the delivery of therapeutic agents to the brain. However, the development of nanotechnology-based approaches for brain delivery, such as nanoparticles, liposomes, dendrimers, micelles, and carbon nanotubes, might be the solution for improved brain therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Current Strategies for Brain Drug Delivery
Dong, X. (2018) · Theranostics · doi:10.7150/thno.21254 · Cited by 954
Blood–brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions
Persidsky, Y., Ramirez, S. H., Haorah, J., & Kanmogne, G. D. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9025-3 · Cited by 922
Attwell, D., Mishra, A., Hall, C. N., O’Farrell, F. M., & Dalkara, T. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15610340 · Cited by 648
Agrawal, M., Saraf, S., Saraf, S., Antimisiaris, S. G., Chougule, M. B., Shoyele, S. A., & Alexander, A. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.05.011 · Cited by 630
Crossing the Blood–Brain Barrier: Recent Advances in Drug Delivery to the Brain
Patel, M. M., & Patel, B. M. (2017) · CNS Drugs · doi:10.1007/s40263-016-0405-9 · Cited by 430
Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier
S. Hersh, D., S. Wadajkar, A., B. Roberts, N., G. Perez, J., P. Connolly, N., Frenkel, V., A. Winkles, J., F. Woodworth, G., & J. Kim, A. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666151221150733 · Cited by 387
The blood-brain barrier: structure, function and therapeutic approaches to cross it.
Tajes, M., Ramos-Fernández, E., Weng-Jiang, X., Bosch-Morató, M., Guivernau, B., Eraso-Pichot, A., Salvador, B., Fernàndez-Busquets, X., Roquer, J., & Muñoz, F. J. (2014) · Molecular Membrane Biology · doi:10.3109/09687688.2014.937468 · Cited by 380
Erickson, M. A., & Banks, W. A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014647 · Cited by 378
Strategies for transporting nanoparticles across the blood–brain barrier
Zhang, T.-T., Li, W., Meng, G., Wang, P., & Liao, W. (2016) · Biomaterials Science · doi:10.1039/c5bm00383k · Cited by 308
Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease
Fonseca-Santos, B., Chorilli, M., & Palmira Daflon Gremião, M. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s87148 · Cited by 308
The Effect of Nanoparticle Size on the Ability to Cross the Blood–Brain Barrier: An In Vivo Study
Betzer, O., Shilo, M., Opochinsky, R., Barnoy, E., Motiei, M., Okun, E., Yadid, G., & Popovtzer, R. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0022 · Cited by 301
He, Q., Liu, J., Liang, J., Liu, X., Li, W., Liu, Z., Ding, Z., & Tuo, D. (2018) · Cells · doi:10.3390/cells7040024 · Cited by 298
Cheng, Y., Dai, Q., Morshed, R. A., Fan, X., Wegscheid, M. L., Wainwright, D. A., Han, Y., Zhang, L., Auffinger, B., Tobias, A. L., et al. (2014) · Small · doi:10.1002/smll.201400654 · Cited by 271
Blood-brain barrier transport machineries and targeted therapy of brain diseases
Barar, J., Rafi, M. A., Pourseif, M. M., & Omidi, Y. (2016) · BioImpacts · doi:10.15171/bi.2016.30 · Cited by 257
Tight junction modulation of the blood brain barrier: CNS delivery of small molecules
Greene, C., & Campbell, M. (2016) · Tissue Barriers · doi:10.1080/21688370.2015.1138017 · Cited by 246
Kafa, H., Wang, J. T.-W., Rubio, N., Venner, K., Anderson, G., Pach, E., Ballesteros, B., Preston, J. E., Abbott, N. J., & Al-Jamal, K. T. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.02.083 · Cited by 214
(2016) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-63432-0.00003-7 · Cited by 202
Lakkadwala, S., & Singh, J. (2019) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2018.09.047 · Cited by 194
Transport of nanoparticles through the blood–brain barrier for imaging and therapeutic applications
Shilo, M., Motiei, M., Hana, P., & Popovtzer, R. (2014) · Nanoscale · doi:10.1039/c3nr04878k · Cited by 193
Barbara, R., Belletti, D., Pederzoli, F., Masoni, M., Keller, J., Ballestrazzi, A., Vandelli, M. A., Tosi, G., & Grabrucker, A. M. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.05.015 · Cited by 180
Delivery of doxorubicin-loaded PLGA nanoparticles into U87 human glioblastoma cells
Malinovskaya, Y., Melnikov, P., Baklaushev, V., Gabashvili, A., Osipova, N., Mantrov, S., Ermolenko, Y., Maksimenko, O., Gorshkova, M., Balabanyan, V., et al. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.03.049 · Cited by 172
Shen, Y., Cao, B., Snyder, N. R., Woeppel, K. M., Eles, J. R., & Cui, X. T. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0340-7 · Cited by 155
Kafa, H., Wang, J. T.-W., Rubio, N., Klippstein, R., Costa, P. M., Hassan, H. A. F. M., Sosabowski, J. K., Bansal, S. S., Preston, J. E., Abbott, N. J., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.031 · Cited by 153
Transferrin-modified liposome promotes α-mangostin to penetrate the blood–brain barrier
Chen, Z., Huang, M., Wang, X.-R., Fu, J., Han, M. Y., Shen, Y., Xia, Z., & Gao, J. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.10.021 · Cited by 146
Nanoscale effects in dendrimer-mediated targeting of neuroinflammation
Nance, E., Zhang, F., Mishra, M. K., Zhang, Z., Kambhampati, S. P., Kannan, R. M., & Kannan, S. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.05.044 · Cited by 142
Lohan, S., Raza, K., Mehta, S. K., Bhatti, G. K., Saini, S., & Singh, B. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.07.080 · Cited by 133
Igartúa, D. E., Martinez, C. S., Temprana, C. F., Alonso, S. D. V., & Prieto, M. J. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.04.032 · Cited by 122
In Vitro Study of Receptor-Mediated Silica Nanoparticles Delivery across Blood–Brain Barrier
Song, Y., Du, D., Li, L., Xu, J., Dutta, P., & Lin, Y. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b03504 · Cited by 121
Blood-brain barrier (BBB) and the complement landscape
Alexander, J. J. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.06.267 · Cited by 121
dos Santos Rodrigues, B., Oue, H., Banerjee, A., Kanekiyo, T., & Singh, J. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.07.043 · Cited by 116
Baghirov, H., Karaman, D. Ş., Viitala, T., Duchanoy, A., Lou, Y., Mamaeva, V., Pryazhnikov, E., Khiroug, L., Davies, C. D. L., Sahlgren, C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160705 · Cited by 113
Patel, H. K., Gajbhiye, V., Kesharwani, P., & Jain, N. K. (2016) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2016.07.047 · Cited by 110
He, C., Cai, P., Li, J., Zhang, T., Lin, L. Q., Abbasi, A. Z., Henderson, J. T., Rauth, A. M., & Wu, X. Y. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.12.019 · Cited by 108
PAMAM dendrimers: blood-brain barrier transport and neuronal uptake after focal brain ischemia
Santos, S. D., Xavier, M., Leite, D. M., Moreira, D. A., Custódio, B., Torrado, M., Castro, R., Leiro, V., Rodrigues, J., Tomás, H., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.10.006 · Cited by 102
L-DOPA functionalized, multi-branched gold nanoparticles as brain-targeted nano-vehicles
Gonzalez‐Carter, D., Ong, Z. Y., McGilvery, C. M., Dunlop, I. E., Dexter, D. T., & Porter, A. E. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.08.011 · Cited by 100
Penetrating the Blood–Brain Barrier: Promise of Novel Nanoplatforms and Delivery Vehicles
Ali, I., & Chen, X. S. (2015) · ACS Nano · doi:10.1021/acsnano.5b05341 · Cited by 98
Zhang, F., Magruder, J. T., Lin, Y.-A., Crawford, T. C., Grimm, J. C., Sciortino, C. M., Wilson, M. A., Blue, M. E., Kannan, S., Johnston, M. V., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.032 · Cited by 92
Convection enhanced delivery of liposome encapsulated doxorubicin for brain tumour therapy
Zhan, W., & Wang, C. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.07.006 · Cited by 87
Ruff, J., Hüwel, S., Kogan, M. J., Simon, U., & Galla, H. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.02.013 · Cited by 84
Yao, P., Zhao, Y., Chen, Y., Yang, Z., Zhang, L., Xiao, W., Yang, J., Guo, L., & Wu, Y. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.08.006 · Cited by 84
Gao, S., Tian, H., Xing, Z., Zhang, D., Guo, Y., Guo, Z., Zhu, X., & Chen, X. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.10.027 · Cited by 83
Lakkadwala, S., & Singh, J. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.07.020 · Cited by 82
Jiang, Y., Lv, L., Shi, H., Hua, Y., Lv, W., Wang, X., Xin, H., & Xu, Q. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.08.002 · Cited by 77
Astrocytes to the rescue! Glia limitans astrocytic endfeet control CNS inflammation
Quintana, F. J. (2017) · Journal of Clinical Investigation · doi:10.1172/jci95769 · Cited by 76
Augmented glioma-targeted theranostics using multifunctional polymer-coated carbon nanodots
Wang, S., Li, C., Qian, M., Jiang, H., Shi, W., Chen, J., Lächelt, U., Wagner, E., Lu, W., Wang, Y., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.05.040 · Cited by 74
Crossing the blood-brain barrier: Glutathione-conjugated poly(ethylene imine) for gene delivery
Englert, C., Trützschler, A., Raasch, M., Buś, T., Borchers, P., Mosig, A. S., Traeger, A., & Schubert, U. S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.08.039 · Cited by 73
Drug targeting strategies into the brain for treating neurological diseases
Barnabas, W. (2019) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2018.10.015 · Cited by 70
Desai, P. P., & Patravale, V. B. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.11.014 · Cited by 69
Shiraishi, K., Wang, Z., Kokuryo, D., Aoki, I., & Yokoyama, M. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.020 · Cited by 62
Kuo, Y., Chen, I.-Y., & Rajesh, R. (2018) · Journal of the Taiwan Institute of Chemical Engineers · doi:10.1016/j.jtice.2018.03.001 · Cited by 59
Fernandes, J., Ghate, V., Mallik, S. B., & Lewis, S. A. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.06.031 · Cited by 58
Tian, C., Asghar, S., Xu, Y., Chen, Z., Zhang, J., Ping, Q., & Xiao, Y. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.09.034 · Cited by 57
Jampílek, J., Záruba, К., Oravec, M., Kuneš, M., Babula, P., Ulbrich, P., Brezániová, I., Opatřilová, R., Třı́ska, J., & Suchý, P. (2015) · BioMed Research International · doi:10.1155/2015/812673 · Cited by 56
Hu, Y., Rip, J., Gaillard, P. J., de Lange, E. C. M., & Hammarlund‐Udenaes, M. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.03.009 · Cited by 51
Targeting of the kynurenic acid across the blood–brain barrier by core-shell nanoparticles
Varga, N., Csapó, E., Majláth, Z., Ilisz, I., Krizbai, I. A., Wilhelm, I., Knapp, L., Toldi, J., Vécsei, L., & Dékány, I. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.02.012 · Cited by 50
Guccione, C., Oufir, M., Piazzini, V., Eigenmann, D. E., Jähne, E. A., Zabela, V., Faleschini, M. T., Bergonzi, M. C., Smieško, M., Hamburger, M. O., et al. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.06.018 · Cited by 48
Bayındır, Z. S., Ergin, A. D., Parmaksız, M., Elçin, A. E., Elçin, Y. M., & Yüksel, N. (2016) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2016.10.003 · Cited by 44
O’Keeffe, E., & Campbell, M. (2016) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2016.07.008 · Cited by 42
Tamba, B.-I., Streinu, V., Foltea, G., Neagu, A.-N., Dodi, G., Zlei, M., Tijani, A., & Ştefănescu, C. (2018) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2018.03.019 · Cited by 42
Godinho, B., Henninger, N., Bouley, J., Alterman, J., Haraszti, R., Gilbert, J. W., Sapp, E., Coles, A. H., Biscans, A., Nikan, M., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.08.005 · Cited by 37
Nanodiagnostics in microbiology and dentistry
Subramani, K., & Mehta, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-812291-4.00019-4 · Cited by 32
Drug Permeation across the Blood-Brain Barrier: Applications of Nanotechnology
Fakhoury, M., Takechi, R., & Al‐Salami, H. (2015) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2015/15493 · Cited by 31
Towards earlier diagnosis and treatment of disorders of the brain
Luca, M. D., Nutt, D., Oertel, W. H., Boyer, P., Jaarsma, J., Destrebecq, F., Esposito, G., & Quoidbach, V. (2018) · Bulletin of the World Health Organization · doi:10.2471/blt.17.206599 · Cited by 29
Yellepeddi, V., Mohammadpour, R., Kambhampati, S. P., Sayre, C. L., Mishra, M. K., Kannan, R. M., & Ghandehari, H. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.04.040 · Cited by 27
Yoon, H.-J., Lee, E., Kang, M., Jeong, Y., & Park, J. (2015) · Journal of Materials Chemistry B · doi:10.1039/c4tb01759e · Cited by 26
Mondal, J., Patra, M., Panigrahi, A. K., & Khuda‐Bukhsh, A. R. (2018) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2017.11.002 · Cited by 25
Sydow, K., Nikolenko, H., Lorenz, D., Müller, R. H., & Dathe, M. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.09.019 · Cited by 22
MRI visualization of neuroinflammation using VCAM-1 targeted paramagnetic micelles
Garello, F., Pagoto, A., Arena, F., Buffo, A., Blasi, F., Alberti, D., & Terreno, E. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.10.002 · Cited by 22
Perspective on brain targeting drug delivery systems
Gao, H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814001-7.00018-4 · Cited by 19
Anatomy and Physiology of the Blood–Brain Barrier
Özdemir, Y., & Taş, Y. Ç. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803796-6.00001-0 · Cited by 14
Cited by
The blood–brain barrier: Structure, regulation and drug delivery
Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01481-w · Cited by 1,906
“104,105 Kinase-like proteins modulate the blood – brain barrier permeability.”
BackgroundRecent advances in polymeric drug delivery systems
Sung, Y. K., & Kim, S. W. (2020) · Biomaterials Research · doi:10.1186/s40824-020-00190-7 · Cited by 732
Clinical translation of nanomedicines: Challenges, opportunities, and keys
Younis, M. A., Tawfeek, H. M., Abdellatif, A. A. H., Abdel-Aleem, J. A., & Harashima, H. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114083 · Cited by 462
Domingues, C., Santos, A., Alvarez-Lorenzo, C., Concheiro, A., Jarak, I., Veiga, F., Barbosa, I., Dourado, M., & Figueiras, A. (2022) · ACS Nano · doi:10.1021/acsnano.2c00128 · Cited by 235
Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases
Masoudi Asil, S., Ahlawat, J., Guillama Barroso, G., & Narayan, M. (2020) · Biomaterials Science · doi:10.1039/d0bm00809e · Cited by 181
Metadata
- Authors
- Teleanu, D. M., Chircov, C., Grumezescu, A. M., Volceanov, A., & Teleanu, R. I.
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2018-12-11
- Volume
- 10
- Issue
- 4
- Pages
- 269
- ISSN
- 1999-4923 (ISSN-L)
- OpenAlex
- W2905538718
- Cited by
- 305
- References
- 70
- FWCI
- 9.20
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.